ArticleFrontiers in oncology2021

Economic Evaluation of Sacituzumab Govitecan for the Treatment of Metastatic Triple-Negative Breast Cancer in China and the US.

Jigang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.